190 related articles for article (PubMed ID: 8440814)
1. Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents.
Brewer GJ; Yuzbasiyan-Gurkan V; Johnson V; Dick RD; Wang Y
J Am Coll Nutr; 1993 Feb; 12(1):26-30. PubMed ID: 8440814
[TBL] [Abstract][Full Text] [Related]
2. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
3. Wilson's disease: current status.
Yarze JC; Martin P; Muñoz SJ; Friedman LS
Am J Med; 1992 Jun; 92(6):643-54. PubMed ID: 1605146
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
6. Zinc therapy in Wilson's disease: observations in five patients.
Rossaro L; Sturniolo GC; Giacon G; Montino MC; Lecis PE; Schade RR; Corazza GR; Trevisan C; Naccarato R
Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance.
Hill GM; Brewer GJ; Juni JE; Prasad AS; Dick RD
Am J Med Sci; 1986 Dec; 292(6):344-9. PubMed ID: 3799705
[TBL] [Abstract][Full Text] [Related]
8. Use of zinc-copper metabolic interactions in the treatment of Wilson's disease.
Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY
J Am Coll Nutr; 1990 Oct; 9(5):487-91. PubMed ID: 2258535
[TBL] [Abstract][Full Text] [Related]
9. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases.
Brewer GJ
Metallomics; 2009; 1(3):199-206. PubMed ID: 21305118
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
Brewer GJ; Johnson VD; Dick RD; Hedera P; Fink JK; Kluin KJ
Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
[TBL] [Abstract][Full Text] [Related]
11. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
Purchase R
Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
Schilsky ML
Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
[TBL] [Abstract][Full Text] [Related]
13. Current Drug Managements of Wilson's Disease: From West to East.
Li WJ; Chen C; You ZF; Yang RM; Wang XP
Curr Neuropharmacol; 2016; 14(4):322-5. PubMed ID: 26639459
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens.
Hill GM; Brewer GJ; Prasad AS; Hydrick CR; Hartmann DE
Hepatology; 1987; 7(3):522-8. PubMed ID: 3570163
[TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic approaches to the treatment of Wilson's disease.
Brewer GJ
Expert Opin Pharmacother; 2006 Feb; 7(3):317-24. PubMed ID: 16448326
[TBL] [Abstract][Full Text] [Related]
16. Recognition, diagnosis, and management of Wilson's disease.
Brewer GJ
Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
[TBL] [Abstract][Full Text] [Related]
17. Interactions of zinc and molybdenum with copper in therapy of Wilson's disease.
Brewer GJ
Nutrition; 1995; 11(1 Suppl):114-6. PubMed ID: 7749256
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Wilson's disease with zinc. 5 cases].
Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
20. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Günther K; Siegemund R; Lössner J; Kühn HJ
Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
